← Back to Search

074-6751 Lotion for Plaque Psoriasis

N/A
Waitlist Available
Research Sponsored by Ferndale Laboratories, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 29
Awards & highlights

Summary

The primary objective of this study is to determine the efficacy and safety of 074-6751 Lotion applied twice daily for four weeks (28 days) in clinical subjects with moderate plaque psoriasis.

Eligible Conditions
  • Plaque Psoriasis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 29
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 29 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline in sum of clinical signs of psoriasis (scaling, erythema, and plaque elevation) scores.
Secondary outcome measures
The proportion of subjects with improvement versus Baseline in IGA score.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 074-6751 LotionExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
074-6751 Lotion
2017
N/A
~100

Find a Location

Who is running the clinical trial?

Ferndale Laboratories, Inc.Lead Sponsor
4 Previous Clinical Trials
213 Total Patients Enrolled
~12 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top